USP10 and non-small cell lung carcinoma: To determine whether inhibition of USP10 activity will achieve similar outcomes to depletion of USP10, we treated three NSCLC cell lines, H1299, H157, and H23, with the USP10 inhibitor Spautin-19, and H1299 with an additional USP10 inhibitor P2207714.